WSA
LLY icon

Wealth Science Advisors’s Eli Lilly LLY Stock Holding History

Wealth Science Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Sell
2,164
-177
-8% -$181K 1.15% 17
2026
Q1 		$2.52M Hold
2,341
– – 1.42% 14
2025
Q4 		$2.52M Buy
+2,341
New +$2.24M 1.45% 14

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Wealth Science Advisors's LLY Position: Q2 2026 in Review

Wealth Science Advisors reduced its Eli Lilly (LLY) stake by 7.6% in Q2 2026, selling an estimated $181K and leaving 2,164 shares worth $2.6M. The position accounts for 1.15% of the portfolio, ranked #17.

Wealth Science Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Science Advisors held 2,164 shares of Eli Lilly worth $2.6M as of Q2 2026.
  • Wealth Science Advisors sold 177 Eli Lilly shares in Q2 2026, an estimated $181K.
  • Eli Lilly made up 1.15% of Wealth Science Advisors's portfolio in Q2 2026, its #17 holding.
  • Wealth Science Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Science Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.